Table 1:

Patient summary

Case No.Age (yr)SexDiseaseLocation of TumorDuration (mo) from GK to MRPNecrosis/RecurrenceRadiation Dosea by GK
145FLung ca.Rt. temporal24Necrosis90%, 22 Gy
Lt. cerebellum18Recurrence54%, 22 Gy
264MLung ca.Rt. cerebellum25Necrosis70%, 21 Gy
370FLung ca.Lt. occipital25Necrosis60%, 22 Gy
475MLung ca.Lt. frontal4Necrosis60%, 22 Gy
578MLung ca.Lt. occipital14Necrosis55%, 20 Gy
664MRenal cell ca.Lt. frontal34Necrosis58%, 20 Gy
Rt. cerebellum18Recurrence55%, 20 Gy
756FBreast ca.Midbrain35Necrosis57%, 20 Gy
868MLung ca.Rt. parietal52Necrosis55%, 21 Gy
976MLung ca.Lt. occipital30Recurrence65%, 22 Gy
1042FBreast ca.Rt. frontal52Recurrence80%, 20 Gy
1175FLung ca.Rt. temporal6Recurrence55%, 22 Gy
1260MLung ca.Lt. frontal14Recurrence52%, 20 Gy
Lt. frontal22Recurrence52%, 20 Gy
1363MLung ca.Lt. frontal14Recurrence53%, 20 Gy
1454FOvarian ca.Rt. parietal7Recurrence54%, 32 Gy
1559MLung ca.Lt. frontal16Recurrence50%, 18 Gy
  • Note:—Rt indicates right; Lt, left; ca., carcinoma; MRP, MR permeability imaging.

  • ↵a A prescription dose of 18–32 Gy at 50%–90% isodose.